Bio

Over nearly 20 years, I have had the opportunity to work for or consult for more than 60 public and private companies around the world. My experience spans a wide range of life science companies and sectors, from pre-seed + seed stage startups to multinational industry leaders. I have lived on 3 continents and conducted business in 20+ countries. Today, I am involved with several companies across the life science and tech space, in some as an active executive, others an advisor, or even a passive investor. At the top of the pyramid, I co-manage The Naissos Group, a family-owned holding company that launches, invests in, and provides advisory services to innovative ventures, with a focus on the life sciences. The portfolio has wholly-owned companies, stealth-mode ventures, and minority positions in outside investments. The lead operational business is TNG Creative, an award-winning, boutique [strategy + creative] consulting firm through which I support several clients across North America, Europe, and Asia, from small early-stage startups to multinational companies and their blockbuster brands. Aside from TNG Creative, we have two stealth-mode ventures that are being actively built and will be revealed soon, Naissos Art and Qoolo. I am also Chief Operating Officer at Oncolyze, an early stage oncology biotech developing a novel therapeutic OM-301 for the treatment of AML and other hematologic and solid cancers. We are actively raising a Series A round to advance that asset into clinical development. Concurrently, I am an Advisor at several other early stage life science companies, including Enterin, Avanzarx, and Prolocor, and an Advisor to SoundTrac Ventures.